Delving into the Latest Updates on Wright State Physicians, Inc. with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Other Diseases

Growth factors

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Growth factors	1

Top 5 Target	Count

IGF-1R(Insulin-like growth factor I receptor)	1

The treatment of allergic contact dermatitis (ACD) can be unsatisfactory, and that other skin diseases such as atopic dermatitis have an increased likelihood of ACD, improved systemic treatments are needed.
This research study explores the effectiveness of Baricitinib in treating Delayed-Type Hypersensitivity (allergic) versus Irritant Skin reactions. Subjects for this study need to be healthy males between the ages of 18 and 40. This study will evaluate this by injecting antigens as well as applying them on top of the skin to the forearm then measure the effects of Baricitinib by skin and blood testing.

Start Date14 Sep 2020

Sponsor / Collaborator

Wright State Physicians, Inc.

100 Clinical Results associated with Wright State Physicians, Inc.

Login to view more data

0 Patents (Medical) associated with Wright State Physicians, Inc.

Login to view more data

100 Deals associated with Wright State Physicians, Inc.

Login to view more data

100 Translational Medicine associated with Wright State Physicians, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data